Palmira Biopharma

is a biopharmaceutical company engaged in the discovery and development of a novel class of therapeutic proteins based on Soluble receptors (“traps”) for a range of serious human diseases, including cardiovascular diseases, ophthalmology and cancer. Today, the Company has seven molecules in the pipeline

Diseases with which we struggle

Traps method

Soluble receptors ("trap") is intended for the treatment of cancer, cardiovascular and eye diseases.

Professional team


Contact me